| Cash Flow | 2025-08-31 |
|---|---|
| Change in fair value of contingent consideration | 0 |
| Net loss | -10,903 |
| Depreciation and amortization | 6,020 |
| Non-cash lease expense | 445 |
| Stock based compensation | 4,470 |
| Deferred income taxes | -16 |
| Change in accounts receivable allowances | 108 |
| Fixed and intangible asset impairments and disposals | -27 |
| Other | -264 |
| Accounts receivable | -139 |
| Inventories | 192 |
| Prepaid expenses and other | 5,525 |
| Accounts payable, accrued and other liabilities | -10,697 |
| Net cash used in operating activities | -15,914 |
| Additions to property, plant and equipment | 731 |
| Additions to placement and evaluation units | 820 |
| Net cash used in investing activities | -1,551 |
| Principal payments on financing arrangement | 91 |
| Repurchase of common stock | 0 |
| Proceeds from exercise of stock options and employee stock purchase plan | 234 |
| Net cash provided by (used in) financing activities | 143 |
| Effect of exchange rate changes on cash and cash equivalents | 191 |
| Decrease in cash and cash equivalents | -17,131 |
| Cash and cash equivalents at beginning of period | 55,893 |
| Cash and cash equivalents at end of period | 38,762 |
ANGIODYNAMICS INC (ANGO)
ANGIODYNAMICS INC (ANGO)